Thomas E. Moon

10.5k total citations · 5 hit papers
107 papers, 7.9k citations indexed

About

Thomas E. Moon is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas E. Moon has authored 107 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 28 papers in Molecular Biology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas E. Moon's work include Sarcoma Diagnosis and Treatment (16 papers), Retinoids in leukemia and cellular processes (9 papers) and Breast Cancer Treatment Studies (8 papers). Thomas E. Moon is often cited by papers focused on Sarcoma Diagnosis and Treatment (16 papers), Retinoids in leukemia and cellular processes (9 papers) and Breast Cancer Treatment Studies (8 papers). Thomas E. Moon collaborates with scholars based in United States, France and Canada. Thomas E. Moon's co-authors include David S. Alberts, Jay W. Mason, Sydney E. Salmon, Brian G.M. Durie, B Soehnlen, Stephen E. Jones, Anne W. Hamburger, Bruce M. McManus, John B. OʼConnell and Noel R. Rose and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Thomas E. Moon

105 papers receiving 7.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Clinical Trial of Immunosuppressive Therapy for Myocarditis

1995 822 citations Jay W. Mason, John B. OʼConnell et al. profile →
Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs

1978 779 citations David S. Alberts, Thomas E. Moon et al. profile →
Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

1976 625 citations Jeffrey A. Gottlieb, Stephen E. Jones et al. Cancer profile →
Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2

2002 512 citations Brian H. Annex, M.J. Whitehouse et al. profile →
The intergroup rhabdomyosarcoma study.A preliminary report

1977 295 citations Thomas E. Moon et al. Cancer profile →

Peers

Countries citing papers authored by Thomas E. Moon

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Moon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Moon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Moon more than expected).

Fields of papers citing papers by Thomas E. Moon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Moon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Moon. The network helps show where Thomas E. Moon may publish in the future.

Co-authorship network of co-authors of Thomas E. Moon

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Moon. A scholar is included among the top collaborators of Thomas E. Moon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Moon. Thomas E. Moon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation 2014 ·Cancer Management and Research ·Jay W. Mason, Thomas E. Moon, (unknown), (unknown)	15
2	Pharmacokinetics and Pharmacodynamics of Three Moxifloxacin Dosage Forms: Implications for Blinding in Active‐Controlled Cardiac Repolarization Studies 2010 ·The Journal of Clinical Pharmacology ·Jay W. Mason, Jeffry Florian, Christine Garnett, Thomas E. Moon, (unknown), (unknown)	24
3	Oritavancin, a New Lipoglycopeptide Antibiotic: Results From a Thorough QT Study 2010 ·The Journal of Clinical Pharmacology ·Börje Darpö, (unknown), Thomas E. Moon, (unknown), Jay W. Mason	11
4	Electrocardiographic reference ranges derived from 79,743 ambulatory subjects 2007 ·Journal of Electrocardiology ·Jay W. Mason, (unknown), D. O. Chanter, Thomas E. Moon, Daniel B. Goodman, Boaz Mendzelevski	253
5	Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial 2001 ·The American Journal of Cardiology ·Robert J. Lederman, Alan N. Tenaglia, R. David Anderson, James Hermiller, Krishna J. Rocha‐Singh, Farrell O. Mendelsohn, William R. Hiatt, Thomas E. Moon, M.J. Whitehouse, Brian H. Annex	22
6	Effects of long-term intake of retinol on selected clinical and laboratory indexes 1999 ·American Journal of Clinical Nutrition ·Brenda Cartmel, Thomas E. Moon, (unknown)	27
7	Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. 1997 ·PubMed ·Thomas E. Moon, Norman Levine, Brenda Cartmel, Jerry L. Bangert, (unknown), Qiong Dong, (unknown), David S. Alberts	145
8	The Myocarditis Treatment Trial: design, methods and patient enrolment 1995 ·European Heart Journal ·Elizabeth A. Hahn, Vernon Hartz, Thomas E. Moon, John B. OʼConnell, A Herskowitz, Bruce M. McManus, Jay W. Mason	40
9	Enhancement of Regression of Cervical Intraepithelial Neoplasia II (Moderate Dysplasia) With Topically Applied All- trans -Retinoic Acid: a Randomized Trial 1994 ·JNCI Journal of the National Cancer Institute ·F. L. Meyskens, Earl A. Surwit, Thomas E. Moon, Joel M. Childers, John R. Davis, Robert T. Dorr, Cynthia S. Johnson, D S Alberts	199
10	Study Design for the Prevention of Aerodigestive Tract Cancers 1992 ·Advances in experimental medicine and biology ·Thomas E. Moon	1
11	Study of Strategies for the Recuitment of Elders Including the Use of Community Volunteers 1992 ·Journal of the American Geriatrics Society ·Brenda Cartmel, Thomas E. Moon	5
12	Comparison of two physical activity questionnaires, with a diary, for assessing physical activity in an elderly population 1992 ·Journal of Clinical Epidemiology ·Brenda Cartmel, Thomas E. Moon	22
13	Planning the analysis of a breast cancer prevention trial 1991 ·Preventive Medicine ·Thomas E. Moon	1
14	The risk of developing subsequent nonmelanoma skin cancers 1990 ·Journal of the American Academy of Dermatology ·Michael M. Schreiber, Thomas E. Moon, (unknown), (unknown)	66
15	Nutrition and cancer prevention: investigating the role of micronutrients. 1989 ·Thomas E. Moon, Marc S. Micozzi	60
16	Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease 1989 ·Cancer ·(unknown), Frank L. Meyskens, (unknown), (unknown), Lois J. Loescher, Thomas E. Moon	35
17	Comparison of Different Trials of Adjuvant Chemotherapy in Stage II Breast Cancer Using a Natural History Data Base 1987 ·American Journal of Clinical Oncology ·Stephen E. Jones, Thomas E. Moon, Gianni Bonadonna, Pinuccia Valagussa, Saul E. Rivkin, Aman U. Buzdar, Eleanor D. Montague, Trevor J. Powles	57
18	Chronic solar ultraviolet damage associated with malignant melanoma of the skin 1984 ·Journal of the American Academy of Dermatology ·Michael M. Schreiber, Thomas E. Moon, (unknown)	16
19	Improved survival of patients with advanced breast cancer treated with adriamycin-cyclophosphamide plus tamoxifen (TAC) 1981 ·Proceedings of the American Association for Cancer Research ·Frederick R. Ahmann, Stephen E. Jones, Thomas E. Moon	3
20	Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Jeffrey A. Gottlieb, Robert S. Benjamin, Laurence H. Baker, Robert M. OʼBryan, J. G. Sinkovics, Barth Hoogstraten, Joseph M. Quagliana, Saul E. Rivkin, G. P. Bodey, V. Rodriguez, G. R. Blumenschein, John H. Saiki, Charles A. Coltman, M. A. Burgess, Patricia Sullivan, Tate Thigpen, R Bottomley, S P Balcerzak, Thomas E. Moon	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact